Division of Gastrointestinal Surgery, Nottingham Digestive Diseases Centre NIHR Biomedical Research Unit, Nottingham University Hospitals, Queen's Medical Centre, Nottingham NG7 2 UH, UK.
Clin Nutr. 2010 Aug;29(4):434-40. doi: 10.1016/j.clnu.2010.01.004. Epub 2010 Jan 29.
BACKGROUND & AIMS: The aim of the Enhanced Recovery After Surgery (ERAS) pathway is to attenuate the stress response to surgery and enable rapid recovery. The objective of this meta-analysis was to study the differences in outcomes in patients undergoing major elective open colorectal surgery within an ERAS pathway and those treated with conventional perioperative care.
Medline, Embase and Cochrane database searches were performed for relevant studies published between January 1966 and November 2009. All randomized controlled trials comparing ERAS with conventional perioperative care were selected. The outcome measures studied were length of hospital stay, complication rates, readmission rates and mortality.
Six randomized controlled trials with 452 patients were included. The number of individual ERAS elements used ranged from 4 to 12, with a mean of 9. The length of hospital stay [weighted mean difference (95% confidence interval): -2.55 (-3.24, -1.85)] and complication rates [relative risk (95% confidence interval): 0.53 (0.44, 0.64)] were significantly reduced in the enhanced recovery group. There was no statistically significant difference in readmission and mortality rates.
ERAS pathways appear to reduce the length of stay and complication rates after major elective open colorectal surgery without compromising patient safety.
强化术后康复(ERAS)方案的目的是减轻手术应激反应,实现快速康复。本荟萃分析旨在研究在 ERAS 方案下接受大型择期开腹结直肠手术的患者与接受常规围手术期治疗的患者之间结局的差异。
检索 1966 年 1 月至 2009 年 11 月发表的相关研究,使用 Medline、Embase 和 Cochrane 数据库。选择所有比较 ERAS 与常规围手术期治疗的随机对照试验。研究的结局指标为住院时间、并发症发生率、再入院率和死亡率。
纳入 6 项包含 452 例患者的随机对照试验。ERAS 方案中使用的单个 ERAS 要素数量从 4 个到 12 个不等,平均 9 个。强化康复组的住院时间[加权均数差(95%置信区间):-2.55(-3.24,-1.85)]和并发症发生率[相对危险度(95%置信区间):0.53(0.44,0.64)]显著降低。再入院率和死亡率无统计学差异。
ERAS 方案似乎可降低大型择期开腹结直肠手术后的住院时间和并发症发生率,且不影响患者安全。